ATE266039T1 - Hiv-protease inhibitoren - Google Patents
Hiv-protease inhibitorenInfo
- Publication number
- ATE266039T1 ATE266039T1 AT96304764T AT96304764T ATE266039T1 AT E266039 T1 ATE266039 T1 AT E266039T1 AT 96304764 T AT96304764 T AT 96304764T AT 96304764 T AT96304764 T AT 96304764T AT E266039 T1 ATE266039 T1 AT E266039T1
- Authority
- AT
- Austria
- Prior art keywords
- group
- hydrocarbon group
- atom
- monocyclic hydrocarbon
- hiv protease
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D277/06—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D263/06—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP18815195 | 1995-06-30 | ||
JP14067896 | 1996-05-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE266039T1 true ATE266039T1 (de) | 2004-05-15 |
Family
ID=26473119
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT96304764T ATE266039T1 (de) | 1995-06-30 | 1996-06-28 | Hiv-protease inhibitoren |
Country Status (9)
Country | Link |
---|---|
US (2) | US5932550A (de) |
EP (1) | EP0751145B1 (de) |
AT (1) | ATE266039T1 (de) |
AU (1) | AU705193B2 (de) |
CA (1) | CA2179935C (de) |
DE (1) | DE69632365T2 (de) |
DK (1) | DK0751145T3 (de) |
ES (1) | ES2220963T3 (de) |
NO (1) | NO314730B1 (de) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6313094B1 (en) | 1990-12-11 | 2001-11-06 | Japan Energy Corporation | β-amino-α-hydroxycarboxylic acid derivatives and HIV protease inhibitors |
EP1039886A4 (de) * | 1997-12-08 | 2001-05-16 | Scripps Research Inst | Ein kleiner p3 rest aufweisende hiv/fiv protease hemmer |
US6803466B1 (en) * | 1997-12-08 | 2004-10-12 | The Scripps Research Institute | HIV/FIV protease inhibitors having a small P3 residue |
US6589962B1 (en) | 1999-07-20 | 2003-07-08 | Merck & Co., Inc. | Alpha-hydroxy-gamma-[[(carbocyclic-or heterocyclic-substituted)amino]carbonyl]alkanamide derivatives and uses thereof |
CA2378480A1 (en) * | 1999-08-09 | 2001-02-15 | Tripep Ab | Pharmaceutical compositions containing tripeptides |
NZ514017A (en) * | 1999-12-28 | 2003-10-31 | Japan Energy Corp | Novel dipeptide compound and medicinal use thereof |
US6287688B1 (en) * | 2000-03-03 | 2001-09-11 | E. I. Du Pont De Nemours And Company | Partially oriented poly(trimethylene terephthalate) yarn |
HN2002000136A (es) * | 2001-06-11 | 2003-07-31 | Basf Ag | Inhibidores de la proteasa del virus hiv, compuestos que contienen a los mismos, sus usos farmaceuticos y los materiales para su sintesis |
US7169932B2 (en) * | 2001-06-11 | 2007-01-30 | Pfizer Inc. | HIV protease inhibitors, compositions containing the same, their pharmaceutical uses, material for their synthesis |
US7094909B2 (en) | 2001-06-11 | 2006-08-22 | Agouron Pharmaceuticals, Inc. | HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
US6593455B2 (en) * | 2001-08-24 | 2003-07-15 | Tripep Ab | Tripeptide amides that block viral infectivity and methods of use thereof |
WO2003024995A1 (en) * | 2001-09-19 | 2003-03-27 | Tripep Ab | Molecules that block viral infectivity and methods of use thereof |
US20050096319A1 (en) * | 2003-02-21 | 2005-05-05 | Balzarini Jan M.R. | Identification of compounds that inhibit replication of human immunodeficiency virus |
EP1603546A1 (de) * | 2003-02-21 | 2005-12-14 | Tripep AB | Glycinamid-derivat zur hemmung der hiv-replikation |
US6955002B2 (en) * | 2003-03-18 | 2005-10-18 | Sandel Medical Industries Llc | Medication marking system |
WO2005026114A1 (en) * | 2003-09-17 | 2005-03-24 | Pfizer Inc. | Hiv protease inhibitors, compositions containing the same and their pharmaceutical uses |
EP1692104A1 (de) * | 2003-12-04 | 2006-08-23 | Pfizer Inc. | Verfahren zur herstellung von als proteaseinhibitoren geeigneten verbindungen |
JP2007513142A (ja) * | 2003-12-04 | 2007-05-24 | ファイザー インコーポレイテッド | プロテアーゼ阻害剤として有用な化合物の製造法 |
KR20060100457A (ko) * | 2003-12-04 | 2006-09-20 | 화이자 인코포레이티드 | 입체이성질체가 증대된 아민의 제조 방법 |
ES2642883T3 (es) * | 2011-05-31 | 2017-11-20 | Theravance Biopharma R&D Ip, Llc | Inhibidores de neprilisina |
WO2012166390A1 (en) | 2011-05-31 | 2012-12-06 | Theravance, Inc. | Neprilysin inhibitors |
EP2714662B1 (de) | 2011-05-31 | 2017-10-11 | Theravance Biopharma R&D IP, LLC | Neprilysin-hemmer |
Family Cites Families (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH03500772A (ja) * | 1987-10-21 | 1991-02-21 | ジ・アップジョン・カンパニー | (1‐アミノ‐2‐ヒドロキシ‐2‐ヘテロサイクリック)エチル基を含有するレニン抑制物質類 |
US4963655A (en) * | 1988-05-27 | 1990-10-16 | Mayo Foundation For Medical Education And Research | Boron analogs of amino acid/peptide protease inhibitors |
US5086165A (en) * | 1989-03-08 | 1992-02-04 | Washington University | Inhibitors of retroviral protease with a ketomethylene isosteric replaced amide bond |
US5342922A (en) * | 1989-03-08 | 1994-08-30 | Washington University | Inhibitors of retroviral protease |
DE3913272A1 (de) * | 1989-04-22 | 1990-10-25 | Hoechst Ag | Dipeptid-derivate mit enzym-inhibitorischer wirkung |
US5212157A (en) * | 1989-06-06 | 1993-05-18 | Bio-Mega, Inc. | Enzyme inhibitors |
US5126326A (en) * | 1989-06-06 | 1992-06-30 | Bio-Mega, Inc. | Enzyme inhibiting peptide derivatives |
DE4001236A1 (de) * | 1990-01-18 | 1991-07-25 | Bayer Ag | Neue peptide, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel, insbesondere als arzneimittel gegen retroviren |
EP0438311A3 (en) * | 1990-01-19 | 1992-07-01 | Merck & Co. Inc. | Di- and tripeptide renin inhibitors |
AU8740991A (en) * | 1990-08-24 | 1992-03-17 | Upjohn Company, The | Peptides containing amino-polyols as transition-state mimics |
US5188950A (en) * | 1990-10-11 | 1993-02-23 | Merck & Co., Inc. | Method of preparing HIV protease inhibitors |
US5192668A (en) * | 1990-10-11 | 1993-03-09 | Merck & Co., Inc. | Synthesis of protease inhibitor |
US5187074A (en) * | 1990-10-11 | 1993-02-16 | Merck & Co., Inc. | Method of hydroxylation with ATCC 55086 |
US5475013A (en) * | 1990-11-19 | 1995-12-12 | Monsanto Company | Retroviral protease inhibitors |
WO1992009297A1 (en) * | 1990-11-30 | 1992-06-11 | Smithkline Beecham Corporation | Hiv protease inhibitors |
CA2056911C (en) * | 1990-12-11 | 1998-09-22 | Yuuichi Nagano | Hiv protease inhibitors |
IL100899A (en) * | 1991-02-08 | 1997-06-10 | Sankyo Co | Beta-amino-alpha- hydroxycarboxylic acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same |
IE922316A1 (en) * | 1991-07-17 | 1993-01-27 | Smithkline Beecham Corp | Retroviral protease inhibitors |
WO1993008184A1 (en) * | 1991-10-23 | 1993-04-29 | Merck & Co., Inc. | Hiv protease inhibitors |
US5644028A (en) * | 1992-05-13 | 1997-07-01 | Japan Energy Corporation | Process for producing peptide derivatives and salts therefor |
AU662434B2 (en) * | 1992-08-07 | 1995-08-31 | Sankyo Company Limited | Peptides capable of inhibiting the activity of HIV protease, their preparation and their use |
US5554653A (en) * | 1992-12-22 | 1996-09-10 | Eli Lilly And Company | Inhibitors of HIV protease useful for the treatment of AIDS |
US5491166A (en) * | 1992-12-22 | 1996-02-13 | Eli Lilly And Company | Inhibitors of HIV protease useful for the treatment of AIDS |
MX9308016A (es) * | 1992-12-22 | 1994-08-31 | Lilly Co Eli | Compuestos inhibidores de la proteasa del virus de la inmunodeficiencia humana, procedimiento para su preparacion y formulacion farmaceutica que los contiene. |
DE69329544T2 (de) * | 1992-12-22 | 2001-05-31 | Lilly Co Eli | HIV Protease hemmende Verbindungen |
US5434265A (en) * | 1992-12-22 | 1995-07-18 | Eli Lilly And Company | Inhibitors of HIV protease |
WO1994018192A1 (en) * | 1993-02-12 | 1994-08-18 | Merck & Co., Inc. | Piperazine derivatives as hiv protease inhibitors |
WO1994026749A1 (en) * | 1993-05-14 | 1994-11-24 | Merck & Co., Inc. | Hiv protease inhibitors |
US5587514A (en) * | 1993-11-08 | 1996-12-24 | Emory University | Diastereoselective synthesis of hydroxyethylene dipeptide isosteres |
US5476874A (en) * | 1994-06-22 | 1995-12-19 | Merck & Co., Inc. | New HIV protease inhibitors |
US5492910A (en) * | 1994-11-17 | 1996-02-20 | Bristol-Myers Squibb Co. | Retrocarbamate protease inhibitors |
AU4953796A (en) * | 1995-03-15 | 1996-10-02 | Sanyko Company, Limited | Dipeptide compounds having ahpba structure |
-
1996
- 1996-06-26 CA CA2179935A patent/CA2179935C/en not_active Expired - Fee Related
- 1996-06-26 US US08/669,757 patent/US5932550A/en not_active Expired - Lifetime
- 1996-06-28 DE DE69632365T patent/DE69632365T2/de not_active Expired - Lifetime
- 1996-06-28 AU AU56285/96A patent/AU705193B2/en not_active Ceased
- 1996-06-28 DK DK96304764T patent/DK0751145T3/da active
- 1996-06-28 ES ES96304764T patent/ES2220963T3/es not_active Expired - Lifetime
- 1996-06-28 EP EP96304764A patent/EP0751145B1/de not_active Expired - Lifetime
- 1996-06-28 AT AT96304764T patent/ATE266039T1/de active
- 1996-06-28 NO NO19962748A patent/NO314730B1/no not_active IP Right Cessation
-
1998
- 1998-08-21 US US09/137,608 patent/US5962640A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
AU705193B2 (en) | 1999-05-20 |
ES2220963T3 (es) | 2004-12-16 |
AU5628596A (en) | 1997-02-06 |
US5962640A (en) | 1999-10-05 |
EP0751145A2 (de) | 1997-01-02 |
NO962748L (no) | 1997-01-02 |
DE69632365D1 (de) | 2004-06-09 |
US5932550A (en) | 1999-08-03 |
EP0751145B1 (de) | 2004-05-06 |
DK0751145T3 (da) | 2004-08-30 |
NO962748D0 (no) | 1996-06-28 |
EP0751145A3 (de) | 1997-10-08 |
CA2179935A1 (en) | 1996-12-31 |
DE69632365T2 (de) | 2005-05-04 |
CA2179935C (en) | 2010-09-07 |
NO314730B1 (no) | 2003-05-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE266039T1 (de) | Hiv-protease inhibitoren | |
BR9206623A (pt) | Uréias cíclicas e análogas úteis como inibidoras da protease retroviral | |
RS20060079A (en) | Novel compounds having inhibitory activity against sodium-dependant transporter | |
NO950297D0 (no) | Prolinamidderivater | |
DK0656887T3 (da) | Hydroxyethylaminosulfonamider til anvendelse som inhibitorer af retrovirale proteaser | |
LU91196I2 (fr) | Picoxystrobin et ses dérivlés pharmaceutiquement acceptables(ACANTO). | |
NO993706D0 (no) | Pyrrolidinderivater med fosfolipase A2 inhiberende aktivitet | |
AUPP150098A0 (en) | Benzamide derivatives | |
HU9300729D0 (en) | Method for producing substituted pyrrholidine derivatives of hiv-protease inhibitor effect and medical preparatives containing them | |
DE69629838D1 (de) | Inhibitoren der kainsäure-neurotoxizität sowie pyridothiazinderivate | |
ATE295166T1 (de) | Aktivatoren der kalium-kanäle | |
DK0417746T3 (da) | N-Azabicyclo(3.3.0)octanamider af aromatiske syrer | |
EP0982029A4 (de) | Vorbeugende /heilmittel fuer arteriosklerose | |
DK0653207T3 (da) | Sammensætning til hæmning af AIDS-virus-infektion | |
DE69220371D1 (de) | Hemmstoff der blutgefässhypertrophie |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 0751145 Country of ref document: EP |